Solero
Payments companies reported to CMS as associated with Solero. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Solero, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Solero
These are the largest totals companies reported as associated with Solero. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Emilio Alonso | Kissimmee, FL | Surgery | $19,597.06 |
| Stephen Vartanian | Farmington Hills, MI | Vascular & Interventional Radiology | $12,819.68 |
| Michael Savin | Royal Oak, MI | Vascular & Interventional Radiology | $12,758.76 |
| Bryan Stover | Grand Junction, CO | Diagnostic Radiology | $6,079.33 |
| Justin Kaptuch | Grand Junction, CO | Diagnostic Radiology | $5,967.36 |
| John Hegstrom | Colorado Springs, CO | Anatomic Pathology & Clinical Pathology | $5,967.36 |
| Brian Flanagan | Grand Junction, CO | Diagnostic Radiology | $5,967.36 |
| Francisco Gortes | Saint Joseph, MO | Vascular & Interventional Radiology | $5,378.80 |
| David Mitchell | Grand Rapids, MI | Vascular & Interventional Radiology | $5,326.39 |
| Charles Cash | Dearborn, MI | Vascular & Interventional Radiology | $4,333.33 |
Prescribed Solero?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.